Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Navigate BioPharma Solutions is a premier specialty contract research organization (CRO) that provides high-complexity clinical trial testing and companion diagnostic development services. Originally established as a subsidiary of Novartis, the company offers advanced expertise in flow cytometry, molecular genomics, and digital pathology to support precision medicine initiatives. They specialize in oncology and immuno-oncology, helping biopharmaceutical partners design and validate biomarker assays for global clinical trials. Following its acquisition by Cerba Research from Labcorp in 2024, Navigate continues to operate as a specialized laboratory focused on accelerating the development of targeted therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Navigate Biopharma Solutions.